drugset / Trial / NCT07479745

Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

NCT07479745 ↗

Phase 1 Recruiting 10 enrolled Grünenthal GmbH
NaSingle-groupOpen-labelBasic science

Summary

The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019

Timeline

Start
2026-03-25
Primary completion
2026-06-06
Completion
2026-06-06

Drugs

EvaluationDrugModalityDoseRoute
Subject GRT6019 Unknown — —

Indications

No indication recorded.